Price Disclosure Is Not Price Transparency: The Case for Navigation-Guided Healthcare Markets

Introduction

Three years after federal hospital price transparency rules took effect, the utilization evidence is difficult to interpret charitably. New Hampshire's public healthcare price transparency website — one of the country's best-resourced and most-publicized — recorded utilization by approximately 1% of eligible consumers in its first three years.¹ Despite that investment in both infrastructure and promotion, aggregate spending in the state followed national trends. Prices were posted. Consumers did not shop.

This outcome was predictable. Price disclosure removes only the first of five documented barriers to healthcare shopping: consumer awareness. It leaves untouched the inability to personalize out-of-pocket cost estimates, the friction of choosing a provider outside one's established referral network, the post-deductible incentive collapse that makes cost-conscious behavior irrational for millions of Americans in the second half of every plan year, and the absence of quality context that would make a lower-priced facility trustworthy.

What has received less attention in the transparency debate is the upstream policy failure that made opaque pricing the default state: the health insurance design decision that removed cost signals from consumers in the first place.

The Insurance Design Failure

Health insurance, when it works as designed, operates on the same principle as every other insurance product. Automobile insurance covers collisions. Homeowners insurance covers fires. Neither covers oil changes or lawn maintenance — predictable, manageable costs that consumers handle through direct market transactions, where prices are visible and competition drives them toward efficiency.

In the 1990s, Health Maintenance Organizations abandoned this design. To encourage preventive care visits, HMOs introduced near-zero copayments — $5 to $10 per visit. What followed was predictable to any student of applied economics: when the marginal cost of an additional physician visit approaches zero, demand expands beyond what patients would purchase if paying directly. This is moral hazard.²

The empirical evidence is unambiguous. The RAND Health Insurance Experiment, which randomized approximately 2,000 families to health plans with varying cost-sharing levels from 1974 to 1982, remains the gold standard study of this mechanism.³ Families with fully free coverage consumed 30% more physician visits and 28% more inpatient admissions than those with substantial cost-sharing. Volume increased. Utilization ratios rose. Premiums followed.

The employer response was the high-deductible health plan. HDHPs restored the cost signal. But the pendulum overcorrected. A $6,000 family deductible does not merely discourage unnecessary office visits; it discourages necessary ones. Survey data indicate that 43% of HDHP enrollees have deferred or skipped recommended care because of cost.⁴ A diabetic patient who skips a specialist visit in January and presents to the emergency department with a preventable complication in March has responded rationally to the financial signal, in clinically counterproductive fashion.

The critical observation is this: the cost signal works. The RAND data confirm it. What was missing from the HDHP era — and what has been missing from the transparency debate — is the infrastructure to make the consumer's response to that signal rational rather than avoidant. A patient who knows that an MRI costs $380 at the independent imaging center across town and $3,200 at the hospital two miles away can make a cost-conscious choice that is also medically sound. A patient who faces a $3,200 price without alternatives visible simply defers the MRI.

Price transparency is the infrastructure that makes cost-sharing work the way it is supposed to. It is not, by itself, sufficient.

What the Evidence Shows Works

Whaley et al., analyzing 2017–2018 employer benefit data, found that prices for imaging procedures fell for consumers who received a direct financial payment to choose lower-cost providers.⁵ The combination of transparency — knowing where the lower-cost option was — with a financial incentive — a reason to choose it — produced the price-shopping behavior that transparency alone did not.

Separately, Christensen et al. found that hospitals subject to price transparency regulation reduced their prices in response, hypothesizing sensitivity to the reputational risk of public identification as a high-price outlier.⁶ The market-discipline effect of transparency reaches provider pricing behavior — but only when the transparency is visible and interpretable enough to create competitive pressure.

A Five-Component Framework

Effective healthcare price transparency requires five components operating together, each addressing a documented barrier to consumer shopping.

AI-guided navigation converts disclosed prices into personalized, plan-aware decisions. An AI care navigation tool can determine a consumer's current deductible accumulation, their carrier's negotiated rate at specific facilities, and the cash-pay alternatives available in their market, then return a ranked recommendation that accounts for both cost and quality. Navigation also functions as a pre-visit triage layer: before a consumer visits an emergency department, AI assessment of the presenting symptoms can redirect 20–30% of visits to lower-cost appropriate settings.⁷

Multi-tier price intelligence presents consumers with the price landscape as it actually exists: the highest in-network rate at the identified facility, the lowest available in-network rate, the best US cash-pay price from transparent-pricing ambulatory surgery centers, and — for elective procedures — international pricing at accredited facilities where savings of 65–80% relative to US network rates are achievable.

Employer-side cost intelligence applies evidence-based clinical algorithms to aggregate claims data, identifying avoidable spending by category. For self-funded employers — 65% of covered workers — claims data contain the full behavioral signal needed to design targeted interventions. Predictive modeling using three-year claims history can project 12- and 24-month spend and quantify the financial impact of specific plan design changes before open enrollment.

Persistent steerage incentives address the post-deductible incentive collapse that renders transparency irrelevant for the majority of high-cost procedures. An employee who has met their $3,000 deductible has no personal financial incentive to choose a $4,000 cash-pay facility over a $28,000 in-network hospital — insurance pays either way. An employer-funded shared savings payment of $500–$1,000 for choosing the surgery center restores the incentive; the employer saves $23,000–$24,000 net. The critical design requirement is that the incentive fire regardless of deductible status.

Primary care incentive realignment through Direct Primary Care eliminates the structural misalignment in fee-for-service primary care. A primary care physician in a traditional practice requires approximately 2,000 panel patients to generate sustainable revenue; income correlates with visit volume, not health outcomes. The DPC model — a monthly subscription of $50–$100 per patient, with panels capped at 200–400 — decouples physician income from volume. Published evidence finds DPC reduces emergency department visits, specialist referrals, and imaging utilization by 20–40%.⁸

The Market Infrastructure Argument

The most consequential implication of this framework operates at a level beyond any individual employer group or consumer: at scale, transparent pricing paired with navigation and incentives produces market-wide price competition.

The Surgery Center of Oklahoma's decision to publish its all-in bundled cash prices was a competitive act. By making its prices visible and lower than the hospital system across town, it redirected volume. Other facilities responded. This is the mechanism of market discipline — the same mechanism that has driven efficiency in every other consumer-facing industry where prices are visible and comparable.

When a sufficient volume of consumers consistently chooses lower-cost, high-value facilities, providers face a genuine competitive signal. Prices fall not only for the consumers who used a transparency tool — but for all patients who subsequently receive care at facilities now competing on price. Price transparency is not a benefit delivered to the individual user of a platform. It is a public good delivered to all participants in the market where transparency-enabled competition takes hold.

This reframes the policy question. The missing policy element is the usability standard: not whether prices are posted, but whether they are actionable. Usability standards, AI navigation safe harbor provisions, and regulatory clarity on steerage incentive design would accelerate the deployment of the navigation layer that converts disclosed prices into market pressure.

Limitations

The five-component framework described here is grounded in published evidence from discrete studies of individual components. Prospective outcome data measuring the interaction effects of all five components operating simultaneously in real employer populations are not yet available. Future research should investigate whether the incentive persistence effect — shared savings applied regardless of deductible status — interacts with copay-before-deductible plan structures in ways that alter its effectiveness.

Conclusions

Price disclosure without navigation is not price transparency. It is a filing requirement. Consumers cannot act on prices they cannot interpret; providers cannot respond to competitive pressure they cannot feel.

The near-zero copayment design introduced by managed care in the 1990s removed the cost signals that produce consumer price sensitivity. The RAND Health Insurance Experiment confirmed that cost signals work. High-deductible plans restored the signal but removed the tools that would allow consumers to respond to it rationally rather than avoidantly. Price transparency mandates created the legal requirement to publish the underlying data. The navigation layer converts that data into the consumer decisions that create market discipline.

Healthcare is not the problem. Healthcare, when prices are visible and facilities compete on them, is affordable. The oil change and the flat tire are manageable costs in a market where prices are visible. Building the framework to make them visible and navigable is not a technology problem. It is a data integration and incentive design problem — solved by putting the right information in front of the right person at the right decision point, paired with a financial reason to act on it. At scale, that is how market discipline returns to healthcare. And how it extends to every participant in the market, not only those who searched for a price.